Comments on the Editorial “Antiphospholypid Syndrome: New Clinical and Therapeutic Perspectives”
Leído
3870
Vecesse ha leído el artículo
2076
Total PDF
1794
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 58 | 17 | 75 |
| 2025 10 | 4 | 67 | 71 |
| 2025 9 | 0 | 49 | 49 |
| 2025 8 | 0 | 51 | 51 |
| 2025 7 | 0 | 34 | 34 |
| 2025 6 | 2 | 29 | 31 |
| 2025 5 | 56 | 28 | 84 |
| 2025 4 | 42 | 25 | 67 |
| 2025 3 | 32 | 17 | 49 |
| 2025 2 | 31 | 29 | 60 |
| 2025 1 | 28 | 51 | 79 |
| 2024 12 | 14 | 21 | 35 |
| 2024 11 | 33 | 39 | 72 |
| 2024 10 | 11 | 21 | 32 |
| 2024 9 | 27 | 22 | 49 |
| 2024 8 | 29 | 26 | 55 |
| 2024 7 | 26 | 28 | 54 |
| 2024 6 | 23 | 20 | 43 |
| 2024 5 | 23 | 20 | 43 |
| 2024 4 | 18 | 17 | 35 |
| 2024 3 | 22 | 24 | 46 |
| 2024 2 | 16 | 15 | 31 |
| 2024 1 | 11 | 17 | 28 |
| 2023 12 | 16 | 19 | 35 |
| 2023 11 | 20 | 13 | 33 |
| 2023 10 | 19 | 30 | 49 |
| 2023 9 | 23 | 37 | 60 |
| 2023 8 | 23 | 16 | 39 |
| 2023 7 | 14 | 25 | 39 |
| 2023 6 | 31 | 24 | 55 |
| 2023 5 | 24 | 12 | 36 |
| 2023 4 | 17 | 7 | 24 |
| 2023 3 | 24 | 30 | 54 |
| 2023 2 | 28 | 27 | 55 |
| 2022 1 | 11 | 23 | 34 |
| 2022 12 | 23 | 34 | 57 |
| 2022 11 | 19 | 27 | 46 |
| 2022 10 | 22 | 33 | 55 |
| 2022 9 | 21 | 45 | 66 |
| 2022 8 | 19 | 38 | 57 |
| 2022 7 | 19 | 36 | 55 |
| 2022 6 | 15 | 27 | 42 |
| 2022 5 | 23 | 51 | 74 |
| 2022 4 | 23 | 37 | 60 |
| 2022 3 | 19 | 33 | 52 |
| 2022 2 | 17 | 30 | 47 |
| 2021 1 | 16 | 30 | 46 |
| 2021 12 | 19 | 37 | 56 |
| 2021 11 | 22 | 43 | 65 |
| 2021 10 | 27 | 35 | 62 |
| 2021 9 | 20 | 39 | 59 |
| 2021 8 | 26 | 38 | 64 |
| 2021 7 | 23 | 21 | 44 |
| 2021 6 | 21 | 38 | 59 |
| 2021 5 | 13 | 29 | 42 |
| 2021 4 | 31 | 52 | 83 |
| 2021 3 | 23 | 25 | 48 |
| 2021 2 | 24 | 20 | 44 |
| 2020 1 | 26 | 20 | 46 |
| 2020 12 | 10 | 12 | 22 |
| 2020 11 | 19 | 18 | 37 |
| 2020 10 | 4 | 5 | 9 |
| 2020 9 | 13 | 20 | 33 |
| 2020 8 | 16 | 11 | 27 |
| 2020 7 | 15 | 20 | 35 |
| 2020 6 | 18 | 19 | 37 |
| 2020 5 | 11 | 11 | 22 |
| 2020 4 | 17 | 18 | 35 |
| 2020 3 | 12 | 3 | 15 |
| 2020 1 | 4 | 0 | 4 |
| 2019 9 | 4 | 0 | 4 |
| 2019 6 | 1 | 0 | 1 |
| 2019 3 | 2 | 0 | 2 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 1 | 1 | 2 |
| 2018 4 | 24 | 17 | 41 |
| 2018 3 | 29 | 16 | 45 |
| 2018 2 | 8 | 7 | 15 |
| 2018 1 | 15 | 8 | 23 |
| 2017 12 | 13 | 10 | 23 |
| 2017 11 | 12 | 10 | 22 |
| 2017 10 | 7 | 15 | 22 |
| 2017 9 | 10 | 4 | 14 |
| 2017 8 | 15 | 14 | 29 |
| 2017 7 | 12 | 15 | 27 |
| 2017 6 | 23 | 13 | 36 |
| 2017 5 | 25 | 7 | 32 |
| 2017 4 | 15 | 3 | 18 |
| 2017 3 | 12 | 5 | 17 |
| 2017 2 | 8 | 3 | 11 |
| 2016 1 | 12 | 3 | 15 |
| 2016 12 | 28 | 9 | 37 |
| 2016 11 | 26 | 5 | 31 |
| 2016 10 | 30 | 9 | 39 |
| 2016 9 | 22 | 3 | 25 |
| 2016 8 | 17 | 7 | 24 |
| 2016 7 | 16 | 7 | 23 |
Mostrar todo
